Do you use biomarkers to improve risk prediction in patients with ADPKD during early disease stages?

Yes. The most important validated prognostic biomarker in early ADPKD is height-adjusted total kidney volume (htTKV), typically measured by MRI and interpreted using the Mayo Imaging Classification. KDIGO recommends htTKV as the preferred imaging biomarker for predicting disease progression and iden...